申请人:Bowen D. Wayne
公开号:US20060004036A1
公开(公告)日:2006-01-05
The present invention relates to sigma-2 receptor agonists and their use in the treatment of immunodeficiency virus infections, especially human immunodeficiency virus (HIV) infections. The invention particularly relates to sigma-2 agonists, especially CB-184 and its analogues, that decrease cellular production of sphingomyelin when provided to recipient cells, and inhibit HIV replication.
本发明涉及sigma-2受体激动剂及其在治疗免疫缺陷病毒感染,特别是人类免疫缺陷病毒(HIV)感染中的用途。本发明尤其涉及σ-2激动剂,特别是CB-184及其类似物,当提供给受体细胞时,它们能减少细胞产生鞘磷脂,并抑制HIV的复制。